| INTRODUCTION
Acne vulgaris is the most common skin disease of adolescents and young adults. 1 It usually causes psychological and social impairments in affected patients. Acne vulgaris is a chronic inflammatory disease of the pilosebaceous follicles, characterized mainly by comedones and inflammatory lesions such as pustules, papules, nodules, cysts, and scars. 2 Its pathogenesis includes sebaceous hypersecretion, follicular hyperkeratinization, follicular colonization by Propionibacterium acnes (P. acnes), and immune and inflammatory responses. 3 Sebaceous glands have an important role in the innate immunity.
They secrete antimicrobial peptides, antibacterial lipids, and neuropeptides. 4 There are many factors which regulate sebaceous glands functions including androgen stimulation, vitamin D, and insulin-like growth factor one. 5 Sebaceous follicles that have microcomedones provide an anaerobic and lipid-rich environment which is ideal for P. acnes activity. 6 Propionibacterium acnes trigger cytokine activation by Toll-like receptors, indicating the role innate immunity in acne development. 7 This immune-mediated inflammation may involve CD4+ lymphocytes and macrophages which stimulates the pilosebaceous vasculature and precede follicular hyperkeratinization. 8 There are several treatment modalities for acne vulgaris including topical and systemic treatments. Topical treatments include topical antibiotics, topical benzoyl peroxide, topical azelaic acid, and topical retinoids. Systemic therapy for acne includes antibiotics, hormonal therapy, and isotretinoin. 7, 8 Isotretinoin (13-cis-retinoic acid) is a synthetic analog of vitamin A. It is the first generation of retinoids that used first in severe case of acne and also it is used in moderate cases to decrease scaring. 2, 6, 9 Isotretinoin decreases acne lesions by several effects including partial inhibition of sebaceous gland function, reduction in keratinization, and suppression of the inflammatory response. The recommended dose of isotretinoin treatment is 0.5-2 mg/kg daily for 3-6 months. 9 There are many side effects for isotretinoin, the most important of which are its teratogenicity, hepatitis, dryness of skin, psychological effects, and cerebral ischemia. In vitro studies identified vitamin D receptors in human sebocytes. 16 Vitamin D has been found to modulate lipid and cytokine production which suggest its possible role in acne pathophysiology. 17 This study aimed to assess serum levels of 25 hydroxy vitamin D in patients with acne vulgaris before and after treatment with isotretinoin and its relation with acne vulgaris severity.
| MATERIALS AND METHODS
This case-control study included 90 patients with moderate to very severe acne vulgaris and 60 age-sex matched healthy subjects as Patients with polycystic ovaries, pregnant and lactating women, women waiting pregnancy during the period of study, patients with renal, gastroenteritis, skeletal, psychiatric, hematological and endocrine disorders and also, patients receiving drugs such as diuretics, multivitamins, anticonvulsants, glucocorticoids, erythromycin, and estrogen compound pills were excluded from the study.
Patients were examined at baseline and after treatments.
Patients were classified according to global acne grading system (GAGS) 18 into moderate, severe, and very severe cases. Body mass index (BMI) was calculated for both patients and controls. All subjects were instructed to use sunscreens with suitable sun protection factor prior to sun exposure.
| Treatment
All patients were treated with isotretinoin (0.75 mg/kg/d) for a period of 3 months. Full blood picture, fasting lipids, and liver function tests have been carried out before and monthly during the treatment period to assess any side effect of treatment.
| Laboratory workup

| Sampling
Blood samples were collected at baseline and at the end of isotretinoin treatment. Ten milliliters of venous blood were withdrawn aseptically from each subject. The samples were divided into two parts: the first was used for CBC, liver functions, and lipid measurement; the second was used for vitamin D level measurement. Blood samples were collected at baseline, 6 weeks, and at the end of isotretinoin treatment (just before discontinuation), and the serum was separated and frozen at À80°C till biochemical testing.
| Vitamin D measurement
Two milliliters of blood was allowed to clot and then centrifuged at 1000 g for 15 minutes, and the serum separated for quantitative determination of 25 hydroxy vitamin D using commercial automated chemiluminescent microparticle immunoassay (Architect, Abbott Diagnostics, New Cairo, Egypt). It is a delayed one-step immunoassay including pretreatment of the sample using 6-point calibration.
In the first step, the sample is pretreated to dissociate the vita- solutions were added to the reaction mixture to produce a chemiluminescent reaction and relative light units were measured.
| Statistical analysis
Analysis of data was carried out by IBM using Statistical Program for Social Sciences (SPSS) software program (version 20). Data were expressed as mean AE standard deviation and n (%). Student's t test and ANOVA were used for comparisons between the study groups.
Paired t test was used for comparison between patients with acne vulgaris before and after treatment. of acne vulgaris before treatment (P = .001) ( Table 2) .
| RESULTS
Furthermore, this study showed that there was a significant difference in serum level of 25 hydroxy vitamin D before and after isotretinoin treatment in patients with acne vulgaris (P = .001) (Table 3 ). There were no significant differences in complete blood pictures, serum lipids, and liver enzymes between patients with acne vulgaris before and 3 months after isotretinoin treatment (Table 3 ).
| DISCUSSION
Acne vulgaris is a multifactorial chronic inflammatory disorder of the pilosebaceous follicles of human skin. Data were expressed as mean AE standard deviation and n (%). Student's t test was used for comparison between the study groups. BMI, body mass index; SD, standard deviation; P value < .05 considered significant. 
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